These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Dynamic expression of matrix metalloproteinases (MMP-2, -9 and -14) and the tissue inhibitors of MMPs (TIMP-1, -2 and -3) at the implantation site during tubal pregnancy. Bai SX; Wang YL; Qin L; Xiao ZJ; Herva R; Piao YS Reproduction; 2005 Jan; 129(1):103-13. PubMed ID: 15615902 [TBL] [Abstract][Full Text] [Related]
25. Cutis laxa: analysis of metalloproteinases and extracellular matrix expression by immunohistochemistry and histochemistry. Gu W; Liu W; Yang X; Yuan X; Tian Y; Meng R; Zhao Q Eur J Dermatol; 2011; 21(5):717-21. PubMed ID: 21719403 [TBL] [Abstract][Full Text] [Related]
26. Downregulation of vascular matrix metalloproteinase inducer and activator proteins in hypertensive patients. Ergul A; Portik-Dobos V; Hutchinson J; Franco J; Anstadt MP Am J Hypertens; 2004 Sep; 17(9):775-82. PubMed ID: 15363819 [TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression. Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745 [TBL] [Abstract][Full Text] [Related]
28. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios. Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742 [TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinases in exercise and obesity. Jaoude J; Koh Y Vasc Health Risk Manag; 2016; 12():287-95. PubMed ID: 27471391 [TBL] [Abstract][Full Text] [Related]
30. Behavior of Metalloproteinases in Adipose Tissue, Liver and Arterial Wall: An Update of Extracellular Matrix Remodeling. Berg G; Barchuk M; Miksztowicz V Cells; 2019 Feb; 8(2):. PubMed ID: 30769840 [TBL] [Abstract][Full Text] [Related]
31. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig. Goetzenich A; Hatam N; Zernecke A; Weber C; Czarnotta T; Autschbach R; Christiansen S J Heart Lung Transplant; 2009 Oct; 28(10):1087-93. PubMed ID: 19782292 [TBL] [Abstract][Full Text] [Related]
32. Investigating metalloproteinases MMP-2 and MMP-9 mechanosensitivity to feedback loops involved in the regulation of in vitro angiogenesis by endogenous mechanical stresses. Dao Thi MU; Trocmé C; Montmasson MP; Fanchon E; Toussaint B; Tracqui P Acta Biotheor; 2012 Jun; 60(1-2):21-40. PubMed ID: 22271286 [TBL] [Abstract][Full Text] [Related]
33. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors. Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831 [TBL] [Abstract][Full Text] [Related]
34. Matrix metalloproteinases, their tissue inhibitors and colorectal cancer staging. Baker EA; Bergin FG; Leaper DJ Br J Surg; 2000 Sep; 87(9):1215-21. PubMed ID: 10971431 [TBL] [Abstract][Full Text] [Related]